-
Therapeutics and Clinical Risk Management
-
About Dovepress
Open access peer-reviewed scientific and medical journals.
-
Open Access
Dove Medical Press is now a member of the Open Access Initiative
-
An Author's Guide
A guide to help authors get their paper published.
-
Advocacy
Support Open Access and Dove Press
-
Reprints
Promotional Article Monitoring - further details
-
Favored Author Program
Real benefits for authors, including fast-track processing of papers.
Asthma exacerbations: prevention is better than cure
(2734) Views (384) Full article downloads
Authors: Dominick E Shaw, Ruth H Green, Peter Bradding
Published Date January 2005
Volume 2005:1(4) Pages 273 - 277
DOI: http://dx.doi.org/10.2147/TCRM.S
Dominick E Shaw, Ruth H Green, Peter Bradding
Institute for Lung Health, Department of Respiratory Medicine and Thoracic Surgery, Glenfield Hospital, Leicester, UK
Abstract: Poorly controlled asthma is currently treated by adding or removing asthma medication in a stepwise fashion to try and improve symptoms and maintain lung function. It is becoming apparent that asthma exacerbations are independent of asthma control and severity, and that the simple method of using rescue courses of corticosteroids to treat an asthma exacerbation can be bettered by aiming to prevent its occurrence. New tools that can predict and prevent exacerbations are now becoming available. This article discusses these tools and takes a more detailed look at new treatment regimes being used.
Keywords: asthma exacerbation, corticosteroids, asthma treatment regimes
- Have an opinion about one of our articles?
We encourage you to write a Letter to the Editor
- American Acne and Rosacea Society
The American Acne and Rosacea Society (AARS), is a 501(c)(6) non-profit organization dedicated to elevating the understanding and treatment of acne and rosacea.
- Tenofovir-associated bone density loss
- The benefits and risks of testosterone replacement therapy: a review
- Drug design with Cdc7 kinase: a potential novel cancer therapy target
- Development of mucosal adjuvants for intranasal vaccine for H5N1 influenza viruses




